Drug Type Fusion protein |
Synonyms ASKG 222, ASKG-222 |
Target |
Mechanism IL-2 replacements(Interleukin-2 replacements) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | - | |
Inflammation | Preclinical | US | - |